The lowering of the price target by Keefe, Bruyette & Woods from $15 to $14 suggests a negative outlook on the stock's short-term price performance. This adjustment reflects the analyst's revised expectations on the company's future performance, which could lead to a decrease in investor confidence and potentially result in a short-term decline in the stock price.